Browse by category

Metabolic benefits of oral polymer-based duodenal exclusion therapy

Glyscend Therapeutics has presented preclinical study results at EASD 2021 evaluating the metabolic effects of once-daily oral therapy in...

Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG

1 day ago

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

1 day ago

Racial and ethnic groups face barriers to obtaining OMMs

1 day ago

Weekly Digest